Detalhe da pesquisa
1.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Clin Infect Dis
; 76(4): 674-682, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906831
2.
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.
J Antimicrob Chemother
; 78(10): 2471-2480, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596890
3.
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Mycoses
; 61(11): 868-876, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035825
4.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet
; 387(10020): 760-9, 2016 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26684607
5.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3406-3413, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961714
6.
Detection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation.
J Clin Microbiol
; 52(7): 2552-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24829249
7.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3501, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029280
8.
Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
Support Care Cancer
; 19(7): 1001-8, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20596732
9.
The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.
Support Care Cancer
; 24(7): 2819-26, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27098065
10.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Lancet Infect Dis
; 19(9): 988-1000, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399377
11.
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
Clin Infect Dis
; 44(10): 1289-97, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17443465
12.
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
Clin Infect Dis
; 42(10): 1404-13, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16619152
13.
Zygomycosis in the immunocompromised patient: a case report.
Acta Biomed
; 77 Suppl 2: 5-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16918059
14.
Febrile neutropenia: a critical review of the initial management.
Crit Rev Oncol Hematol
; 78(3): 185-94, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20413323
15.
Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
Transplantation
; 87(8): 1240-5, 2009 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19384173
16.
An Aspergillus myocardial abscess diagnosed by echocardiography.
J Am Soc Echocardiogr
; 21(10): 1177.e3-5, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18222638
17.
Empiric therapy for febrile neutropenia: what are the choices?
Expert Rev Anti Infect Ther
; 5(3): 507-15, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17547514
18.
Review: additional anti-gram-positive antibiotics do not reduce all-cause mortality in cancer and febrile neutropenia.
ACP J Club
; 144(1): 3, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16388553